Private Placement

As AI demand reshapes the digital world, industry leaders will gather at the infra/STRUCTURE Summit to navigate a critical 'interlude' and redefine strategy.

A 3-year study of COVID survivors reveals a startling new risk: late-onset cognitive impairment, pushing for a radical shift in long-term brain monitoring.

With a new CEO known for billion-dollar deals, Modulari-T Biosciences is poised to commercialize its next-gen in vivo cell therapy platform.

EcoMatcher's new 'Tree Personas' let you chat with your gifted tree via an AI personality, blending digital engagement with real-world conservation.

The Japanese IT giant launches a new investment arm in Singapore, joining a wave of corporate capital chasing growth and innovation in the region's booming tech sector.

Millions suffer from osteoporosis, but many refuse injections. Now, a biotech company's oral pill aims to bridge a massive treatment gap. Here's how.

PomeGran Inc. launches NIVO for Business, offering enterprise-grade fibre internet to underserved regions and aiming to fuel economic growth in Northern Ontario.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

As crypto traders drown in data, DSCVR's new AI subscription promises to turn noise into actionable intelligence. Is this the future of Web3 investing?

Tenvie Therapeutics begins human trials for TNV108, a drug that targets the root cause of nerve decay, offering a potential disease-modifying breakthrough.

Upcoming Phase 1 data for ABCL635 could validate a novel antibody approach for hot flashes, challenging the market and offering new hope for millions.

Publicly traded CNTN releases its Q1 2026 report on the Canton Network, revealing institutional adoption metrics and a unique token model for finance.

Legendary investor John Doerr's new tracker reveals soaring EV sales and renewable power, but warns that lagging industries leave the world far off track.

A 35-year veteran who built a billion-dollar dental health empire is betting on AI to fix the industry's broken administrative backbone. Here's why.

A Shanghai-based firm's new approach could create cancer-fighting cells inside the body, slashing costs and wait times for CAR-T therapy.

Ibero Mining has secured C$500,000 in a critical financing deal aimed at resolving regulatory issues and advancing its gold and copper projects in Portugal.

Amid strong investor demand, RPX Gold increases its capital raise to C$12.3M, signaling a major push for its promising Wawa Gold Project in Ontario.

In a crowded market, Zomee's focus on human support, not just tech, earned it a top spot on USA TODAY's first-ever list of most trusted parent brands.

A new tokenized offering bundles 100 IP-based companies, pioneering an industrialized approach to innovation finance amid growing regulatory clarity.

With a $50M state investment and a new White House directive, Texas is pioneering ibogaine research. But can it overcome the drug's risks and legal hurdles?